The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorSegeberger Kliniken GmbH

About this trial

A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing Recanalization for Coronary Chronic Total Occlusion Lesion/s

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with coronary chronic total occlusions undergoing recanalization via percutaneous coronary interventions

Disqualifiers

None

Trial population

Patients with coronary chronic total occlusions undergoing recanalization vie percutaneous coronary interventions

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Revascularization/Conservative management

    Procedure/Surgery

    Percutaneous Transluminal Angioplasty of Coronary Chronic Total Occlusions via Dedicated Drug Eluting Stents and/or Balloons.

Treatment groups

1,500 Participants
are divided into 1 treatment group
Group A: Patients with Coronary Chronic Total Occlusions1 intervention

Trial outcomes

Primary outcomes

1

Rate of in-hospital and long-term cardiovascular adverse events in percent

Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death)

Time frame
2 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.